OTC Markets OTCPK - Delayed Quote USD
Merck KGaA (MKGAF)
136.00
-0.05
(-0.04%)
As of June 4 at 3:47:51 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 14 | 14 |
Avg. Estimate | 5.34B | 5.42B | 21.62B | 22.45B |
Low Estimate | 5.28B | 5.36B | 21.36B | 21.7B |
High Estimate | 5.43B | 5.5B | 22.05B | 23.07B |
Year Ago Sales | 5.35B | 5.27B | 21.16B | 21.62B |
Sales Growth (year/est) | -0.15% | 2.87% | 2.21% | 3.83% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MKGAF | -- | -- | -- | -- |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Related Tickers
SBX.BE SynBiotic SE
3.0250
-4.12%
EVT.VI Evotec SE
7.00
-1.77%
HMDCF HUTCHMED (China) Limited
3.2050
-15.99%
ARYX ARYx Therapeutics, Inc.
0.0000
0.00%
2HQ.DU Tilray Brands Inc
0.3490
-0.82%
VIVE.ST Vivesto AB
0.2300
-1.50%
TEV.SG Teva Pharmaceutical Industries Ltd
15.20
0.00%
SFZNz.XC
AQS.V Aequus Pharmaceuticals Inc.
0.0050
0.00%
ISCNF Isracann Biosciences Inc.
0.0001
0.00%